Clinical trial of a DC vaccine administered into irradiated tumours in RCC

Our lab obtained first data from a new clinical trial of a DC vaccine administered into irradiated tumours in RCC. Three patients were enrolled and DC vaccine was produced. However only one patient received the vaccine due to cancer progression in the other two patients. The DC were labelled with 111In. The following patients will receive DC labelled with Endorem and the vaccine will be imaged with MRI. The patient treated is in complete remission 6 months after treatment.

• cell type
• dendritic cell

• organism type
• Homo sapiens

• molecule type
• 111Indium,
• Endorem

• experimental design type
• in vivo design experiment

created over 16 years ago (2 March 2009)    last modified over 13 years ago (14 May 2012)   [ RDF ]   [ RelFinder ]